THE MECHANISMS OF THE RESISTANCE TO ANDROGEN ABLATION TREATMENT IN PROSTATE CANCER CELLS
Main Article Content
Abstract
Introduction: Prostate neoplasm is an important health problem, which is especially common in older age
men. Although the standard treatment of metastatic prostate neoplasm is androgen ablation, the resistance to
the treatment will develop in most of the patients, in time. There is no efficient treatment modality for these
patients. It is required to determine the changes in prostate cancer cells to prevent the development of
treatment resistance.
Androgens are important in prostate development, and the androgen ablation and receptor blockade are
effective treatment modalities in prostate cancer. For these reasons, it is inevitable for androgen receptors to
play a role in the development of resistance to hormonal treatment. Since prostate cancer is a heterogeneous
disease, it is necessary to investigate the different mechanisms which may have a role in e disease progression.